Tripelennamine

Relepost 20 MG/G Barra Cutanea

20 mg/g barra cutáneaSpainMarketedAuthorised 17 Apr 2023

In other countries

The same active substances on other registers, the same brand first.

Bug Bite BalmCanada · 1.00 % · Cream · Magically Gone INCSame form
Vagin-XCanada · 2 % · Cream · Associated National Brokerage INC.Same form
Vaginex W Tripelennamine CRM 2%Canada · 2 % / % · Cream · Julius Schmid Canada LTD.Same form
Azaron, crème 20 mg/gNetherlands · Crème · Omega Pharma Nederland B.V.Same form
Azaron Stick, stift 20 mg/gNetherlands · Huidstift · Omega Pharma Nederland B.V.Same substance
PBZUnited States · 25MG HYDROCHLORIDE/5ML · elixir · NovartisSame substance
PBZUnited States · 25MG, 50MG · tablet · NovartisSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Tripelennamine

Relepost 20 MG/G Barra Cutanea

20 mg/g barra cutáneaSpainMarketedAuthorised 17 Apr 2023

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

PBZ-SRUnited States · 100MG, 50MG · tablet, extended release · Novartis

Packs

Pack	Code	Status
RELEPOST 20 MG/G BARRA CUTANEA, 1 aplicador con 5,7 g	762521

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Tripelennamine
Strength: 20 mg/g
Dosage form: barra cutánea
Route: uso cutáneo
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 17 Apr 2023
Registration: 88786
Marketing authorisation holder: Perrigo Espana S.A.
Procedure: National, MRP or DCP
Supply: Sin Receta